Search Results - "Vaitkus, Paul"

Refine Results
  1. 1

    Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients by Leizorovicz, Alain, Cohen, Alexander T, Turpie, Alexander G G, Olsson, Carl-Gustav, Vaitkus, Paul T, Goldhaber, Samuel Z

    Published in Circulation (New York, N.Y.) (17-08-2004)
    “…Considerable variability exists in the use of pharmacological thromboprophylaxis among acutely ill medical patients, partly because clinically relevant end…”
    Get full text
    Journal Article
  2. 2

    Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients by Vaitkus, Paul T, Leizorovicz, Alain, Cohen, Alexander T, Turpie, Alexander G G, Olsson, Carl-Gustav, Goldhaber, Samuel Z

    Published in Thrombosis and haemostasis (01-01-2005)
    “…The clinical importance of asymptomatic proximal and distal deep vein thrombosis (DVT) remains uncertain and controversial. The aim of this retrospective,…”
    Get more information
    Journal Article
  3. 3

    A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention by Vaitkus, Paul T

    Published in The Journal of invasive cardiology (01-05-2004)
    “…While each of the available femoral arterial sealing devices claims equivalent safety to manual compression following invasive cardiac procedures, these claims…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Outcome of Heart Transplantation in Patients With Sarcoid Cardiomyopathy by Zaidi, Asim R., MD, Zaidi, Ali, MD, Vaitkus, Paul T., MD, MBA

    “…Background Cardiac transplantation has been utilized increasingly in patients with sarcoid cardiomyopathy. We sought to review outcomes in patients with…”
    Get full text
    Journal Article
  6. 6

    Risks of noncardiac surgery after coronary stenting by Reddy, Proddutur R., Vaitkus, Paul T.

    Published in The American journal of cardiology (15-03-2005)
    “…An increased risk of major complications for noncardiac surgery after coronary stenting has been suggested. We retrospectively reviewed all cases of coronary…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Assessment of a novel software tool in the selection of aortic valve prosthesis size for transcatheter aortic valve replacement by Vaitkus, Paul T, Wang, Dee Dee, Greenbaum, Adam, Guerrero, Mayra, O'Neill, William

    Published in The Journal of invasive cardiology (01-07-2014)
    “…Transcatheter aortic valve replacement (TAVR) can be complicated by significant paravalvular leak (PVL). Optimal selection of TAVR prosthesis size can minimize…”
    Get more information
    Journal Article
  9. 9

    Can We Appropriately Measure Appropriateness? by Vaitkus, Paul T., MD

    “…In the case of left-main intervention, large amounts of data have been and continue to be published that this is a viable clinical alternative (6).\n These…”
    Get full text
    Journal Article
  10. 10

    N -Acetylcysteine in the prevention of contrast-induced nephropathy: Publication bias perpetuated by meta-analyses by Vaitkus, Paul T., MD, MBA, Brar, Charanjit, RN, MSc, MSN

    Published in The American heart journal (01-02-2007)
    “…Background The use of N -acetylcysteine for the prevention of contrast-induced nephropathy has been the subject of numerous clinical trials and meta-analyses…”
    Get full text
    Journal Article
  11. 11

    Left atrial appendage closure with amplatzer septal occluder in patients with atrial fibrillation: CT-based morphologic considerations by Vaitkus, Paul T, Wang, Dee Dee, Guerrero, Mayra, Greenbaum, Adam, O'Neill, William

    Published in The Journal of invasive cardiology (01-05-2015)
    “…This study analyzed left atrial appendage (LAA) dimensions measured by computed tomography (CT) scan to define optimal selection of Amplatzer septal occluders…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Thromboprophylaxis with dalteparin in medical patients: which patients benefit? by Cohen, Alexander T., Turpie, Alexander G.G., Leizorovicz, Alain, Olsson, Carl-Gustav, Vaitkus, Paul T., Goldhaber, Samuel Z.

    Published in Vascular medicine (London, England) (01-05-2007)
    “…It is unclear whether thromboprophylaxis produces a consistent risk reduction in different subgroups of medical patients at risk from venous thromboembolism…”
    Get full text
    Journal Article
  16. 16

    Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates by Cotton, Cynthia L., Gandhi, Sanjay, Vaitkus, Paul T., Massad, Malek G., Benedetti, Enrico, Mrtek, Robert G., Wiley, Thelma E.

    Published in Liver transplantation (01-11-2002)
    “…Portopulmonary hypertension (PPHTN) is a recognized complication of end-stage liver disease that adversely affects the outcome of orthotopic liver…”
    Get full text
    Journal Article
  17. 17

    Effect of stents in reducing restenosis in small coronary arteries: A meta-analysis by Vaitkus, Paul T.

    “…The ability of stents to reduce restenosis was established in larger coronary arteries. Clinical trials of stenting in smaller vessels have yielded conflicting…”
    Get full text
    Journal Article
  18. 18

    Treatment of Malignant Pericardial Effusion by Vaitkus, Paul T, Herrmann, Howard C, LeWinter, Martin M

    “…Objective.—To discuss the diagnosis and treatment of malignant pericardial Objective.—To fusion and focus on quantitating the success and complication rates of…”
    Get full text
    Journal Article
  19. 19
  20. 20